Increased sclerostin levels after further ablation of remnant estrogen by aromatase inhibitors.
Kim W, Chung Y, Kim SH, Park S, Bae JH, Kim G, Lee SJ, Kim JE, Park BW, Lim SK, Rhee Y.
Kim W, et al. Among authors: kim g, kim sh, kim je.
Endocrinol Metab (Seoul). 2015 Mar 27;30(1):58-64. doi: 10.3803/EnM.2015.30.1.58. Epub 2014 Jul 2.
Endocrinol Metab (Seoul). 2015.
PMID: 25827459
Free PMC article.